4th Annual MarketsandMarkets

Epigenetics Congress

3 - 4 October 2019

Radisson Blu Edwardian, Grafton Hotel, London

25+

Speakers

120+

Attendees

10+

Networking Hours

5+

Sessions

While most of the molecular studies focus over mutational analysis, epigenetics-is the only science which is gaining momentum with its cheaper and faster technology, by making its way to the clinic. Moving on the path of clinical epigenetics, this congress will discuss the solutions to challenges like, drug discovery, identification of molecular inhibitors, gene modification and analysis.

Tag Line
Learn from academia and industry experts about clinical epigenetics, discussing solutions to challenges like drug discovery, identification of molecular inhibitors, gene modification and analysis.
Tag Line
Our expert speaker panel will address emergence of novel drugs and next-generation diagnostic technologies with respect to huge growth, government funding for epigenetics research. The congress will host effective mix of case studies, panel discussion and presentations on development of epigenetics, translational epigenetics, clinical epigenetics and more.
Tag Line
Engage with pioneers and leaders from academia and industry and stay updated with the latest advancement in epigenetics research right from drug discovery to identification of molecular inhibitors to gene modifications and analysis.

WHAT TO EXPECT

Epigenetic modification | Genomic profiling | Transcriptional mechanism | Molecular inhibitors | Epigenetic modulators | Clinical applications of epigenetics

Heads, Directors, Group Leaders, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from Pharmaceutical, Bio-pharmaceutical and Research Institutes

Epigenetics | Developmental Epigenetics | Epidemiology | Molecular Biology | Developmental Biology | Biological Sciences | Biochemistry | Medicinal Chemistry | Pharmaceutical chemistry 

CONFERENCE AGENDA

Registration

08:00 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening Remarks from the Chairman

Ronan Murphy

Ronan Murphy , Assciate Editor, Clinical Epigenetics , Dublin City University

09:00 - 09:05

DEVELOPMENT OF EPIGENETICS

Emerging Portfolio of Novel Epigenetic Inhibitors

Daniel Dransfield

Daniel Dransfield, Vice President, Biology, Epizyme

09:05 - 09:40

High-resolution economical profiling of epigenetic DNA modifications using TOP-seq

Saulius Klimasauskas

Saulius Klimasauskas, Director and Distinguished Professor, Institute of Biotechnology, Vilnius University

09:40 - 10:15

Robst Sample Preparation Solutions for Chromatin-based Applications

Angela Garding

Angela Garding, Field Application Scientist, Covaris

10:15 - 10:45

Morning Refreshments | Poster Presentations | One-to-One Networking

10:45 - 11:35

The Potential of Select BET Inhibition for High Risk Vascular Diseases

Kenneth Lebioda

Kenneth Lebioda, Senior Vice President, Business & Corporate Development, Reservlogix

11:35 - 12:05

Importance of investigating epigenetic alterations for industry and regulators

Rémi Terranova

Rémi Terranova , Principle Investigator, Preclinical safety, Novartis Institutes for BioMedical Research, Switz

12:05 - 12:40

Drugging transcription: Progress and potential for treating human immune dysfunction

Inma Rioja

Inma Rioja , Senior Director & Portfolio Research Lead at Epige, GSK

12:40 - 13:10

Lunch | Poster Presentations | One-to-One Networking

13:10 - 14:10

TRANSLATIONAL EPIGENETICS

Development of novel therapeutic anticancer approach with HDAC inhibitors: from the bench to the bedside

Alfredo Budillon

Alfredo Budillon , Chief Experimental Pharmacology Unit Department of, Istituto Nazionale tumori G. Pascale

14:10 - 14:45

Selective’ targeting of transcriptional scaffolding

Panagis Filippakopoulos

Panagis Filippakopoulos , Associate Professor, Structural Genomics Consortiu, University of Oxford

14:45 - 15:20

Evening Refreshments | Poster Presentations | One-to-One Networking

15:20 - 16:10

Platelets: Functional biomarkers of epigenetic drift

Ronan Murphy

Ronan Murphy , Assciate Editor, Clinical Epigenetics , Dublin City University

16:10 - 16:45

Making sense of disease-linked non-coding mutations

Mikhail Spivakov

Mikhail Spivakov , Group leader and Honorary Senior Lecturer, MRC Lon, Imperial College

16:45 - 17:20

Probing HDACs and bromodomains in cancer with small molecule designer libraries

John Spencer

John Spencer, Professor, Bioorganic Chemistry, University of Sussex

17:20 - 17:55

Closing Remarks by the Chair

17:55 - 18:00

End of Day 1

18:00 - 18:10

Drink Reception & Networking

18:00 - 19:00

Registration

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening Remarks from the Chairman

Dr. Tamara Maes

Dr. Tamara Maes , Chief Scientific Officer, Oryzon, Spain

09:00 - 09:10

CLINICAL EPIGENETICS

Histone demethylase inhibitors in CNS and oncology- LSD1 inhibitors iadademstat and vafidemstat from bench to bedside

Dr. Tamara Maes

Dr. Tamara Maes , Chief Scientific Officer, Oryzon, Spain

09:05 - 09:40

Epigenetic in drug development: a discovery safety perspective

Ambra Bianco

Ambra Bianco, Associate Principal Scientist, AstraZeneca

09:40 - 10:15

The epigenetic protein SP140 directs inflammatory activation of macrophages in crohn’s disease

Mohammed Ghiboub

Mohammed Ghiboub, Researcher, Amsterdam UMC

10:15 - 10:50

Morning Refreshments | Poster Presentations | One-to-One Networking

10:50 - 11:40

DNA methylation as an epigenetic factor in psychiatric disorders and their treatment

Gavin Reynolds

Gavin Reynolds , Professor Emeritus , Queens University Belfast

11:40 - 12:15

Challenges in targeting histone demethylases

Christopher Schofield

Christopher Schofield , Head of Organic Chemistry, University of Oxford and fellow of Royal society,

12:15 - 12:50

Lunch | Poster Presentations | One-to-One Networking

12:50 - 13:50

Pancreatic islet chromatin dynamics and type 1 diabetes genetic architecture

Lorenzo Pasquali

Lorenzo Pasquali, Group Leader of the Endocrine Regulatory Genomics laboratory, IGTP

13:50 - 14:25

Using imaging flow cytometry for epigenetics studies and drug development

Ziv Porat

Ziv Porat, Staff Scientist, Weizmann Institute

14:25 - 15:00

Closing remarks by Chairperson

15:00 - 15:05

End of Conference

15:05 - 15:10

SPEAKERS

Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Board Member, MarketsandMarkets

Rémi Terranova

Rémi Terranova

Principle Investigator, Preclinical safety, Novartis Institutes for BioMedical Research, Switz

Inma Rioja

Inma Rioja

Senior Director & Portfolio Research Lead at Epige, GSK

Ronan Murphy

Ronan Murphy

Assciate Editor, Clinical Epigenetics , Dublin City University

Saulius Klimasauskas

Saulius Klimasauskas

Director and Distinguished Professor, Institute of Biotechnology, Vilnius University

Alfredo Budillon

Alfredo Budillon

Chief Experimental Pharmacology Unit Department of, Istituto Nazionale tumori G. Pascale

Panagis Filippakopoulos

Panagis Filippakopoulos

Associate Professor, Structural Genomics Consortiu, University of Oxford

Christopher Schofield

Christopher Schofield

Head of Organic Chemistry, University of Oxford and fellow of Royal society,

Ziv Porat

Ziv Porat

Staff Scientist, Weizmann Institute

Lorenzo Pasquali

Lorenzo Pasquali

Group Leader of the Endocrine Regulatory Genomics laboratory, IGTP

Mikhail Spivakov

Mikhail Spivakov

Group leader and Honorary Senior Lecturer, MRC Lon, Imperial College

Dan Dransfield

Dan Dransfield

Vice President, Biology , Epizyme

Gavin Reynolds

Gavin Reynolds

Professor Emeritus , Queens University Belfast

John Spencer

John Spencer

Professor, Bioorganic Chemistry, University of Sussex

Kenneth Lebioda

Kenneth Lebioda

Senior Vice President, Business & Corporate Development, Reservlogix

Dr. Tamara Maes

Dr. Tamara Maes

Chief Scientific Officer, Oryzon, Spain

Angela Garding

Angela Garding

Field Application Scientist, Covaris

Mohammed Ghiboub

Mohammed Ghiboub

Researcher, Amsterdam UMC

Ambra Bianco

Ambra Bianco

Associate Principal Scientist, AstraZeneca

ENQUIRE NOW

SPONSORS

PARTNERS

LOCATION

Venue

Radisson Blu Edwardian, Grafton Hotel, London

PAST EVENT GALLERY